C158H158F2N26O8 — CID 159661343
2-[6-(1-cyclopropylpyrazol-4-yl)isoquinolin-3-yl]-1-[2-(4-methylpiperazin-1-yl)-4-pyridinyl]ethanone;1-[4-(1-fluoroethoxy)phenyl]-2-[6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]isoquinolin-3-yl]ethanone;1-(3-fluorophenyl)-2-[6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]isoquinolin-3-yl]ethanone;2-[6-(3-methylimidazol-4-yl)isoquinolin-3-yl]-1-(4-methylphenyl)ethanone;1-(4-methylphenyl)-2-[6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]isoquinolin-3-yl]ethanone;1-[5-[2-[6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]isoquinolin-3-yl]acetyl]-2-pyridinyl]propan-1-one (PubChem CID 159661343) has the molecular formula C158H158F2N26O8 and a molecular weight of 2587.17 g/mol. Its IUPAC name is 2-[6-(1-cyclopropylpyrazol-4-yl)isoquinolin-3-yl]-1-[2-(4-methylpiperazin-1-yl)-4-pyridinyl]ethanone;1-[4-(1-fluoroethoxy)phenyl]-2-[6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]isoquinolin-3-yl]ethanone;1-(3-fluorophenyl)-2-[6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]isoquinolin-3-yl]ethanone;2-[6-(3-methylimidazol-4-yl)isoquinolin-3-yl]-1-(4-methylphenyl)ethanone;1-(4-methylphenyl)-2-[6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]isoquinolin-3-yl]ethanone;1-[5-[2-[6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]isoquinolin-3-yl]acetyl]-2-pyridinyl]propan-1-one.
| Compound Name | 2-[6-(1-cyclopropylpyrazol-4-yl)isoquinolin-3-yl]-1-[2-(4-methylpiperazin-1-yl)-4-pyridinyl]ethanone;1-[4-(1-fluoroethoxy)phenyl]-2-[6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]isoquinolin-3-yl]ethanone;1-(3-fluorophenyl)-2-[6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]isoquinolin-3-yl]ethanone;2-[6-(3-methylimidazol-4-yl)isoquinolin-3-yl]-1-(4-methylphenyl)ethanone;1-(4-methylphenyl)-2-[6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]isoquinolin-3-yl]ethanone;1-[5-[2-[6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]isoquinolin-3-yl]acetyl]-2-pyridinyl]propan-1-one |
|---|---|
| PubChem CID | 159661343 |
| Molecular Formula | C158H158F2N26O8 |
| Molecular Weight | 2587.17 g/mol |
| Exact Mass | 2585.27 |
| IUPAC Name | 2-[6-(1-cyclopropylpyrazol-4-yl)isoquinolin-3-yl]-1-[2-(4-methylpiperazin-1-yl)-4-pyridinyl]ethanone;1-[4-(1-fluoroethoxy)phenyl]-2-[6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]isoquinolin-3-yl]ethanone;1-(3-fluorophenyl)-2-[6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]isoquinolin-3-yl]ethanone;2-[6-(3-methylimidazol-4-yl)isoquinolin-3-yl]-1-(4-methylphenyl)ethanone;1-(4-methylphenyl)-2-[6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]isoquinolin-3-yl]ethanone;1-[5-[2-[6-[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]isoquinolin-3-yl]acetyl]-2-pyridinyl]propan-1-one |
| SMILES | CC(F)Oc1ccc(C(=O)Cc2cc3cc(-c4cnn(C5CCN(C)CC5)c4)ccc3cn2)cc1.CCC(=O)c1ccc(C(=O)Cc2cc3cc(-c4cnn(C5CCN(C)CC5)c4)ccc3cn2)cn1.CN1CCC(n2cc(-c3ccc4cnc(CC(=O)c5cccc(F)c5)cc4c3)cn2)CC1.CN1CCN(c2cc(C(=O)Cc3cc4cc(-c5cnn(C6CC6)c5)ccc4cn3)ccn2)CC1.Cc1ccc(C(=O)Cc2cc3cc(-c4cncn4C)ccc3cn2)cc1.Cc1ccc(C(=O)Cc2cc3cc(-c4cnn(C5CCN(C)CC5)c4)ccc3cn2)cc1 |
| InChI | InChI=1S/C28H29FN4O2.C28H29N5O2.C27H28N6O.C27H28N4O.C26H25FN4O.C22H19N3O/c1-19(29)35-27-7-5-20(6-8-27)28(34)15-25-14-23-13-21(3-4-22(23)16-30-25)24-17-31-33(18-24)26-9-11-32(2)12-10-26;1-3-27(34)26-7-6-21(16-30-26)28(35)14-24-13-22-12-19(4-5-20(22)15-29-24)23-17-31-33(18-23)25-8-10-32(2)11-9-25;1-31-8-10-32(11-9-31)27-14-20(6-7-28-27)26(34)15-24-13-22-12-19(2-3-21(22)16-29-24)23-17-30-33(18-23)25-4-5-25;1-19-3-5-20(6-4-19)27(32)15-25-14-23-13-21(7-8-22(23)16-28-25)24-17-29-31(18-24)26-9-11-30(2)12-10-26;1-30-9-7-25(8-10-30)31-17-22(16-29-31)18-5-6-20-15-28-24(13-21(20)11-18)14-26(32)19-3-2-4-23(27)12-19;1-15-3-5-16(6-4-15)22(26)11-20-10-19-9-17(7-8-18(19)12-24-20)21-13-23-14-25(21)2/h3-8,13-14,16-19,26H,9-12,15H2,1-2H3;4-7,12-13,15-18,25H,3,8-11,14H2,1-2H3;2-3,6-7,12-14,16-18,25H,4-5,8-11,15H2,1H3;3-8,13-14,16-18,26H,9-12,15H2,1-2H3;2-6,11-13,15-17,25H,7-10,14H2,1H3;3-10,12-14H,11H2,1-2H3 |
| InChIKey | MSVQMGSBKZRMKJ-UHFFFAOYSA-N |
| XLogP | 28.67 |
| TPSA | 358.20 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 34 |
| Rotatable Bonds | 34 |
| Heavy Atoms | 194 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2587.17 |
| LogP ≤ 5 | 28.67 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 34 |